1 Bio-pharma Market Overview 1.1 Product Overview and Scope of Bio-pharma 1.2 Bio-pharma Segment by Type 1.2.1 Global Bio-pharma Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Monoclonal Antibodies 1.2.3 Recombinant Proteins 1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF) 1.2.5 Interferons 1.2.6 Recombinant Human Insulin 1.2.7 Erythropoietin 1.2.8 Vaccines 1.2.9 Growth Hormones 1.2.10 Purified Proteins 1.2.11 Others 1.3 Bio-pharma Segment by Application 1.3.1 Global Bio-pharma Sales Comparison by Application: (2021-2027) 1.3.2 Metabolic Disorders 1.3.3 Oncology 1.3.4 Neurological Disorders 1.3.5 Cardiovascular Diseases 1.3.6 Inflammatory and Infectious Diseases 1.3.7 Others 1.4 Global Bio-pharma Market Size Estimates and Forecasts 1.4.1 Global Bio-pharma Revenue 2016-2027 1.4.2 Global Bio-pharma Sales 2016-2027 1.4.3 Bio-pharma Market Size by Region: 2016 Versus 2021 Versus 2027 2 Bio-pharma Market Competition by Manufacturers 2.1 Global Bio-pharma Sales Market Share by Manufacturers (2016-2021) 2.2 Global Bio-pharma Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Bio-pharma Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Bio-pharma Manufacturing Sites, Area Served, Product Type 2.5 Bio-pharma Market Competitive Situation and Trends 2.5.1 Bio-pharma Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Bio-pharma Players Market Share by Revenue 2.5.3 Global Bio-pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Bio-pharma Retrospective Market Scenario by Region 3.1 Global Bio-pharma Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Bio-pharma Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Bio-pharma Market Facts & Figures by Country 3.3.1 North America Bio-pharma Sales by Country 3.3.2 North America Bio-pharma Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Bio-pharma Market Facts & Figures by Country 3.4.1 Europe Bio-pharma Sales by Country 3.4.2 Europe Bio-pharma Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Bio-pharma Market Facts & Figures by Region 3.5.1 Asia Pacific Bio-pharma Sales by Region 3.5.2 Asia Pacific Bio-pharma Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Bio-pharma Market Facts & Figures by Country 3.6.1 Latin America Bio-pharma Sales by Country 3.6.2 Latin America Bio-pharma Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Bio-pharma Market Facts & Figures by Country 3.7.1 Middle East and Africa Bio-pharma Sales by Country 3.7.2 Middle East and Africa Bio-pharma Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Bio-pharma Historic Market Analysis by Type 4.1 Global Bio-pharma Sales Market Share by Type (2016-2021) 4.2 Global Bio-pharma Revenue Market Share by Type (2016-2021) 4.3 Global Bio-pharma Price by Type (2016-2021) 5 Global Bio-pharma Historic Market Analysis by Application 5.1 Global Bio-pharma Sales Market Share by Application (2016-2021) 5.2 Global Bio-pharma Revenue Market Share by Application (2016-2021) 5.3 Global Bio-pharma Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Bio-pharma Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 F. Hoffmann-La Roche AG 6.2.1 F. Hoffmann-La Roche AG Corporation Information 6.2.2 F. Hoffmann-La Roche AG Description and Business Overview 6.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.2.4 F. Hoffmann-La Roche AG Bio-pharma Product Portfolio 6.2.5 F. Hoffmann-La Roche AG Recent Developments/Updates 6.3 Johnson & Johnson Services 6.3.1 Johnson & Johnson Services Corporation Information 6.3.2 Johnson & Johnson Services Description and Business Overview 6.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Johnson & Johnson Services Bio-pharma Product Portfolio 6.3.5 Johnson & Johnson Services Recent Developments/Updates 6.4 Sanofi, Amgen 6.4.1 Sanofi, Amgen Corporation Information 6.4.2 Sanofi, Amgen Description and Business Overview 6.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi, Amgen Bio-pharma Product Portfolio 6.4.5 Sanofi, Amgen Recent Developments/Updates 6.5 AbbVie 6.5.1 AbbVie Corporation Information 6.5.2 AbbVie Description and Business Overview 6.5.3 AbbVie Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.5.4 AbbVie Bio-pharma Product Portfolio 6.5.5 AbbVie Recent Developments/Updates 6.6 Merck & Co., Inc 6.6.1 Merck & Co., Inc Corporation Information 6.6.2 Merck & Co., Inc Description and Business Overview 6.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Merck & Co., Inc Bio-pharma Product Portfolio 6.6.5 Merck & Co., Inc Recent Developments/Updates 6.7 Biogen Idec 6.6.1 Biogen Idec Corporation Information 6.6.2 Biogen Idec Description and Business Overview 6.6.3 Biogen Idec Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Biogen Idec Bio-pharma Product Portfolio 6.7.5 Biogen Idec Recent Developments/Updates 6.8 Bayer AG 6.8.1 Bayer AG Corporation Information 6.8.2 Bayer AG Description and Business Overview 6.8.3 Bayer AG Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Bayer AG Bio-pharma Product Portfolio 6.8.5 Bayer AG Recent Developments/Updates 6.9 Eli Lilly and Company 6.9.1 Eli Lilly and Company Corporation Information 6.9.2 Eli Lilly and Company Description and Business Overview 6.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Eli Lilly and Company Bio-pharma Product Portfolio 6.9.5 Eli Lilly and Company Recent Developments/Updates 6.10 Novartis AG GlaxoSmithKline Plc 6.10.1 Novartis AG GlaxoSmithKline Plc Corporation Information 6.10.2 Novartis AG GlaxoSmithKline Plc Description and Business Overview 6.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Product Portfolio 6.10.5 Novartis AG GlaxoSmithKline Plc Recent Developments/Updates 6.11 Bristol-Myers Squibb Company 6.11.1 Bristol-Myers Squibb Company Corporation Information 6.11.2 Bristol-Myers Squibb Company Bio-pharma Description and Business Overview 6.11.3 Bristol-Myers Squibb Company Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Bristol-Myers Squibb Company Bio-pharma Product Portfolio 6.11.5 Bristol-Myers Squibb Company Recent Developments/Updates 6.12 AstraZeneca PLC 6.12.1 AstraZeneca PLC Corporation Information 6.12.2 AstraZeneca PLC Bio-pharma Description and Business Overview 6.12.3 AstraZeneca PLC Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.12.4 AstraZeneca PLC Bio-pharma Product Portfolio 6.12.5 AstraZeneca PLC Recent Developments/Updates 6.13 Abbott Laboratories 6.13.1 Abbott Laboratories Corporation Information 6.13.2 Abbott Laboratories Bio-pharma Description and Business Overview 6.13.3 Abbott Laboratories Bio-pharma Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Abbott Laboratories Bio-pharma Product Portfolio 6.13.5 Abbott Laboratories Recent Developments/Updates 7 Bio-pharma Manufacturing Cost Analysis 7.1 Bio-pharma Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Bio-pharma 7.4 Bio-pharma Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Bio-pharma Distributors List 8.3 Bio-pharma Customers 9 Bio-pharma Market Dynamics 9.1 Bio-pharma Industry Trends 9.2 Bio-pharma Growth Drivers 9.3 Bio-pharma Market Challenges 9.4 Bio-pharma Market Restraints 10 Global Market Forecast 10.1 Bio-pharma Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Bio-pharma by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Bio-pharma by Type (2022-2027) 10.2 Bio-pharma Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Bio-pharma by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Bio-pharma by Application (2022-2027) 10.3 Bio-pharma Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Bio-pharma by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Bio-pharma by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Bio-pharma Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Bio-pharma Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Bio-pharma Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Bio-pharma Covered in This Study Table 5. Global Bio-pharma Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Bio-pharma Sales Market Share by Manufacturers (2016-2021) Table 7. Global Bio-pharma Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Bio-pharma Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Bio-pharma Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Bio-pharma Manufacturing Sites and Area Served Table 11. Manufacturers Bio-pharma Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Bio-pharma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio-pharma as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Bio-pharma Sales by Region (2016-2021) & (K Pcs) Table 16. Global Bio-pharma Sales Market Share by Region (2016-2021) Table 17. Global Bio-pharma Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Bio-pharma Sales by Country (2016-2021) & (K Pcs) Table 19. North America Bio-pharma Sales Market Share by Country (2016-2021) Table 20. North America Bio-pharma Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Bio-pharma Revenue Market Share by Country (2016-2021) Table 22. Europe Bio-pharma Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Bio-pharma Sales Market Share by Country (2016-2021) Table 24. Europe Bio-pharma Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Bio-pharma Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Bio-pharma Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Bio-pharma Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Bio-pharma Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Bio-pharma Revenue Market Share by Region (2016-2021) Table 30. Latin America Bio-pharma Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Bio-pharma Sales Market Share by Country (2016-2021) Table 32. Latin America Bio-pharma Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Bio-pharma Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Bio-pharma Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Bio-pharma Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Bio-pharma Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Bio-pharma Revenue Market Share by Country (2016-2021) Table 38. Global Bio-pharma Sales (K Pcs) by Type (2016-2021) Table 39. Global Bio-pharma Sales Market Share by Type (2016-2021) Table 40. Global Bio-pharma Revenue (Million US$) by Type (2016-2021) Table 41. Global Bio-pharma Revenue Share by Type (2016-2021) Table 42. Global Bio-pharma Price (USD/Pcs) by Type (2016-2021) Table 43. Global Bio-pharma Sales (K Pcs) by Application (2016-2021) Table 44. Global Bio-pharma Sales Market Share by Application (2016-2021) Table 45. Global Bio-pharma Revenue (Million US$) by Application (2016-2021) Table 46. Global Bio-pharma Revenue Share by Application (2016-2021) Table 47. Global Bio-pharma Price (USD/Pcs) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Pfizer Bio-pharma Product Table 52. Pfizer Recent Developments/Updates Table 53. F. Hoffmann-La Roche AG Corporation Information Table 54. F. Hoffmann-La Roche AG Description and Business Overview Table 55. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. F. Hoffmann-La Roche AG Bio-pharma Product Table 57. F. Hoffmann-La Roche AG Recent Developments/Updates Table 58. Johnson & Johnson Services Corporation Information Table 59. Johnson & Johnson Services Description and Business Overview Table 60. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Johnson & Johnson Services Bio-pharma Product Table 62. Johnson & Johnson Services Recent Developments/Updates Table 63. Sanofi, Amgen Corporation Information Table 64. Sanofi, Amgen Description and Business Overview Table 65. Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Sanofi, Amgen Bio-pharma Product Table 67. Sanofi, Amgen Recent Developments/Updates Table 68. AbbVie Corporation Information Table 69. AbbVie Description and Business Overview Table 70. AbbVie Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. AbbVie Bio-pharma Product Table 72. AbbVie Recent Developments/Updates Table 73. Merck & Co., Inc Corporation Information Table 74. Merck & Co., Inc Description and Business Overview Table 75. Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. Merck & Co., Inc Bio-pharma Product Table 77. Merck & Co., Inc Recent Developments/Updates Table 78. Biogen Idec Corporation Information Table 79. Biogen Idec Description and Business Overview Table 80. Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. Biogen Idec Bio-pharma Product Table 82. Biogen Idec Recent Developments/Updates Table 83. Bayer AG Corporation Information Table 84. Bayer AG Description and Business Overview Table 85. Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 86. Bayer AG Bio-pharma Product Table 87. Bayer AG Recent Developments/Updates Table 88. Eli Lilly and Company Corporation Information Table 89. Eli Lilly and Company Description and Business Overview Table 90. Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 91. Eli Lilly and Company Bio-pharma Product Table 92. Eli Lilly and Company Recent Developments/Updates Table 93. Novartis AG GlaxoSmithKline Plc Corporation Information Table 94. Novartis AG GlaxoSmithKline Plc Description and Business Overview Table 95. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 96. Novartis AG GlaxoSmithKline Plc Bio-pharma Product Table 97. Novartis AG GlaxoSmithKline Plc Recent Developments/Updates Table 98. Bristol-Myers Squibb Company Corporation Information Table 99. Bristol-Myers Squibb Company Description and Business Overview Table 100. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 101. Bristol-Myers Squibb Company Bio-pharma Product Table 102. Bristol-Myers Squibb Company Recent Developments/Updates Table 103. AstraZeneca PLC Corporation Information Table 104. AstraZeneca PLC Description and Business Overview Table 105. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 106. AstraZeneca PLC Bio-pharma Product Table 107. AstraZeneca PLC Recent Developments/Updates Table 108. Abbott Laboratories Corporation Information Table 109. Abbott Laboratories Description and Business Overview Table 110. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 111. Abbott Laboratories Bio-pharma Product Table 112. Abbott Laboratories Recent Developments/Updates Table 113. Production Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Bio-pharma Distributors List Table 116. Bio-pharma Customers List Table 117. Bio-pharma Market Trends Table 118. Bio-pharma Growth Drivers Table 119. Bio-pharma Market Challenges Table 120. Bio-pharma Market Restraints Table 121. Global Bio-pharma Sales Forecast by Type (2022-2027) & (K Pcs) Table 122. Global Bio-pharma Sales Market Share Forecast by Type (2022-2027) Table 123. Global Bio-pharma Revenue Forecast by Type (2022-2027) & (US$ Million) Table 124. Global Bio-pharma Revenue Market Share Forecast by Type (2022-2027) Table 125. Global Bio-pharma Sales Forecast by Application (2022-2027) & (K Pcs) Table 126. Global Bio-pharma Sales Market Share Forecast by Application (2022-2027) Table 127. Global Bio-pharma Revenue Forecast by Application (2022-2027) & (US$ Million) Table 128. Global Bio-pharma Revenue Market Share Forecast by Application (2022-2027) Table 129. Global Bio-pharma Sales Forecast by Region (2022-2027) & (K Pcs) Table 130. Global Bio-pharma Sales Market Share Forecast by Region (2022-2027) Table 131. Global Bio-pharma Revenue Forecast by Region (2022-2027) & (US$ Million) Table 132. Global Bio-pharma Revenue Market Share Forecast by Region (2022-2027) Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Bio-pharma Figure 2. Global Bio-pharma Market Share by Type in 2020 & 2027 Figure 3. Monoclonal Antibodies Product Picture Figure 4. Recombinant Proteins Product Picture Figure 5. Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture Figure 6. Interferons Product Picture Figure 7. Recombinant Human Insulin Product Picture Figure 8. Erythropoietin Product Picture Figure 9. Vaccines Product Picture Figure 10. Growth Hormones Product Picture Figure 11. Purified Proteins Product Picture Figure 12. Others Product Picture Figure 13. Global Bio-pharma Market Share by Application in 2020 & 2027 Figure 14. Metabolic Disorders Figure 15. Oncology Figure 16. Neurological Disorders Figure 17. Cardiovascular Diseases Figure 18. Inflammatory and Infectious Diseases Figure 19. Others Figure 20. Global Bio-pharma Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 21. Global Bio-pharma Market Size 2016-2027 (US$ Million) Figure 22. Global Bio-pharma Sales 2016-2027 (K Pcs) Figure 23. Global Bio-pharma Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 24. Bio-pharma Sales Share by Manufacturers in 2020 Figure 25. Global Bio-pharma Revenue Share by Manufacturers in 2020 Figure 26. The Global 5 and 10 Largest Bio-pharma Players: Market Share by Revenue in 2020 Figure 27. Bio-pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 28. Global Bio-pharma Sales Market Share by Region (2016-2021) Figure 29. Global Bio-pharma Sales Market Share by Region in 2020 Figure 30. Global Bio-pharma Revenue Market Share by Region (2016-2021) Figure 31. Global Bio-pharma Revenue Market Share by Region in 2020 Figure 32. U.S. Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Canada Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Germany Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. France Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. U.K. Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Italy Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Russia Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. China Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Japan Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. South Korea Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. India Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Australia Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Taiwan Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Indonesia Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Thailand Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Malaysia Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Philippines Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Vietnam Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Mexico Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Brazil Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. Argentina Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. Turkey Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. Saudi Arabia Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.A.E Bio-pharma Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Sales Market Share of Bio-pharma by Type (2016-2021) Figure 57. Sales Market Share of Bio-pharma by Application (2016-2021) Figure 58. Sales Market Share of Bio-pharma by Application in 2020 Figure 59. Revenue Share of Bio-pharma by Application (2016-2021) Figure 60. Revenue Share of Bio-pharma by Application in 2020 Figure 61. Manufacturing Cost Structure of Bio-pharma Figure 62. Manufacturing Process Analysis of Bio-pharma Figure 63. Bio-pharma Industrial Chain Analysis Figure 64. Channels of Distribution Figure 65. Distributors Profiles Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Pfizer F. Hoffmann-La Roche AG Johnson & Johnson Services Sanofi, Amgen AbbVie Merck & Co., Inc Biogen Idec Bayer AG Eli Lilly and Company Novartis AG GlaxoSmithKline Plc Bristol-Myers Squibb Company AstraZeneca PLC Abbott Laboratories